Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M546Revenue $M14.2Net Margin (%)-810.9Z-Score7.1
Enterprise Value $M316EPS $-3.3Operating Margin %-986.7F-Score2
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-810.9Higher ROA y-yY
Price/Book1.910-y EBITDA Growth Rate %-9.1Quick Ratio11.9Cash flow > EarningsN
Price/Sales41.35-y EBITDA Growth Rate %25.2Current Ratio11.9Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-32.8Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-38.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M41.3ROI % (ttm)-300.9Gross Margin Increase y-yN

Gurus Latest Trades with SRPT

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SRPTGeorge Soros 2014-09-30 Reduce-0.08%$19.9 - $30.27
($22.49)
$ 13.21-41%Reduce -52.21%325,000
SRPTGeorge Soros 2014-06-30 Add0.14%$22.18 - $38.91
($31.64)
$ 13.21-58%Add 2620%680,000
SRPTGeorge Soros 2014-03-31 Reduce-0.04%$17.91 - $30.29
($25.36)
$ 13.21-48%Reduce -89.27%25,000
SRPTGeorge Soros 2013-12-31 Reduce-0.22%$12.89 - $53.81
($29.58)
$ 13.21-55%Reduce -64.98%233,000
SRPTGeorge Soros 2013-09-30 Add0.12%$30.906 - $47.97
($38.37)
$ 13.21-66%Add 56.28%665,274
SRPTAndreas Halvorsen 2013-09-30 Sold Out -0.14%$30.906 - $47.97
($38.37)
$ 13.21-66%Sold Out0
SRPTAndreas Halvorsen 2013-03-31 Buy 0.15%$23.97 - $36.95
($28.83)
$ 13.21-54%New holding, 690731 sh.690,731
SRPTGeorge Soros 2013-03-31 Add0.08%$23.97 - $36.95
($28.83)
$ 13.21-54%Add 82.54%413,329
SRPTGeorge Soros 2012-12-31 Add0.05%$14.99 - $44.93
($26.74)
$ 13.21-51%Add 184.13%226,429
SRPTJean-Marie Eveillard 2012-03-31 Sold Out $4.5 - $9.6
($6.06)
$ 13.21118%Sold Out0
SRPTJean-Marie Eveillard 2011-12-31 Reduce$3.24 - $6.54
($5.04)
$ 13.21162%Reduce -83.33%50,000
SRPTJean-Marie Eveillard 2011-09-30 Add$6.3 - $9.9
($7.92)
$ 13.2167%Add 50%300,000
SRPTJean-Marie Eveillard 2011-06-30 Buy $8.1 - $11.22
($9.66)
$ 13.2137%New holding, 200000 sh.200,000
SRPTGeorge Soros 2006-03-31 Buy 0.08%$24.54 - $50.45
($41.39)
$ 13.21-68%New holding, 308100 sh.308,100
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SRPT is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
SRPT George Soros 2014-09-30325,0000.790.05-52.21%
Premium Most recent portfolio changes are included for Premium Members only!


SRPT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CHASE ANTHONY RDirector 2013-11-14Buy10,000$13.95-2.01view
Aphale JayantSVP Technical Operations 2013-11-12Sell15,933$12.568.84view
BEHRENS M KATHLEENDirector 2013-09-16Buy6,500$37.04-63.09view
HODGMAN JOHNDirector 2013-09-03Sell5,556$34.97-60.91view
CHASE ANTHONY RDirector 2013-08-22Buy3,500$32.68-58.17view
Mahatme SandeshSenior Vice President, CFO 2013-08-20Buy5,000$31.1-56.05view
Price Ben GilDirector 2013-08-19Buy500$31.18-56.16view
CHASE ANTHONY RDirector 2013-06-14Buy10,000$38.5-64.49view
CHASE ANTHONY RDirector 2012-11-28Sell10,000$29.46-53.6view
CHASE ANTHONY RDirector 2012-11-14Sell10,000$25.7-46.81view

Press Releases about SRPT :

    Quarterly/Annual Reports about SRPT:

    News about SRPT:

    Articles On GuruFocus.com
    Ebola: Is The Cure Out There? Oct 14 2014 
    Insiders Are Buying Fate Therapeutics Oct 09 2013 
    comment on SRPT Mar 16 2013 
    comment on SRPT Mar 16 2013 
    comment on SRPT Feb 16 2013 

    More From Other Websites
    SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Sarepta... Dec 16 2014
    EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Against Sarepta... Dec 09 2014
    SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Sarepta... Dec 09 2014
    INVESTOR ALERT: Class Action Lawsuit Against Sarepta Therapeutics, Inc. Announced by Glancy Binkow &... Dec 08 2014
    Biotech Stock Mailbag: Aethlon Medical, Oxigene, Sarepta Dec 05 2014
    Sarepta DMD Community Update Call scheduled for 11:00 am ET today Dec 02 2014
    Sarepta Therapeutics upgraded by WBB Securities Nov 26 2014
    It was another slow, low volume, lackluster trading session Nov 24 2014
    Sarepta Therapeutics to Host Webcast and Conference Call for the Duchenne Muscular Dystrophy... Nov 24 2014
    BioMarin's Prosensa Buy: A 'Courageous' Acquisition? Nov 24 2014
    BioMarin Buys Prosensa Backs Up Troubled Drug Nov 24 2014
    Stock Futures Trending Higher; Kate Spade Bags An Upgrade Nov 24 2014
    Sarepta Therapeutics to Present Company Overview at Upcoming Conferences Nov 24 2014
    Sarepta Therapeutics to Present Company Overview at Upcoming Conferences Nov 24 2014
    Sarepta Therapeutics Announces First Patient Dosed in Confirmatory Study of Eteplirsen in Ambulant... Nov 21 2014
    Robbins Arroyo LLP Is Investigating the Officers and Directors of Sarepta Therapeutics, Inc. (SRPT)... Nov 18 2014
    Sarepta Therapeutics Announces First Patient Dosed in Confirmatory Study of Eteplirsen in Ambulant... Nov 18 2014
    INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000... Nov 14 2014
    SAREPTA THERAPEUTICS, INC. Financials Nov 14 2014
    Sarepta Initiates Dosing for Study Evaluating Eteplirsen Nov 13 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK